Mvasi (bevacizumab-awwb recalls

The FDA has published 1 recall involving Mvasi (bevacizumab-awwb since 2022. The latest was reported on 18 May 2022. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2022

Last 12 months0reported

Class I00% of total

Ongoing0latest 18 May 2022

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why mvasi (bevacizumab-awwb is recalled

Other Reasons1100%

Companies

Amgen1100%

By year

20221100%

All mvasi (bevacizumab-awwb recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
18 May 2022Drug	CLASS II	Mvasi (bevacizumab-awwb), Injection recalled by Amgen	Amgen	Other	Nationwide

Should you stop taking Mvasi (bevacizumab-awwb?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.